June 22, 2022

Acer Therapeutics, Relief Therapeutics Receive CRL From FDA For ACER-001 For UCDs

(RTTNews) – Pharmaceutical company Acer Therapeutics Inc. (ACER) and its collaboration partner, Relief Therapeutics Holding SA (RLFTF, RLFTY), announced Tuesday that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug App

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!

X